Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies
Open accessThe DOI matches its Crossref record; 125 of the 126 references it cites were found in a registry or an index, and 1 are not checked yet; none of the 9 sources its claims cite is checked for support yet.
Abstract
BACKGROUND: Positive association between obesity and survival after breast cancer was demonstrated in previous meta-analyses of published data, but only the results for the comparison of obese versus non-obese was summarised. METHODS: We systematically searched in MEDLINE and EMBASE for follow-up studies of breast cancer survivors with body mass index (BMI) before and after diagnosis, and total and cause-specific mortality until June 2013, as part of the World Cancer Research Fund Continuous Update Project. Random-effects meta-analyses were conducted to explore the magnitude and the shape of the associations. RESULTS: Eighty-two studies, including 213 075 breast cancer survivors with 41 477 deaths (23 182 from breast cancer) were identified. For BMI before diagnosis, compared with normal weight women, the summary relative risks (RRs) of total mortality were 1.41 [95% confidence interval (CI) 1.29-1.53] for obese (BMI >30.0), 1.07 (95 CI 1.02-1.12) for overweight (BMI 25.0-<30.0) and 1.10 (95% CI 0.92-1.31) for underweight (BMI <18.5) women. For obese women, the summary RRs were 1.75 (95% CI 1.26-2.41) for pre-menopausal and 1.34 (95% CI 1.18-1.53) for post-menopausal breast cancer. For each 5 kg/m(2) increment of BMI before, <12 months after, and ≥12 months after diagnosis, increased risks of 17%, 11%, and 8% for total mortality, and 18%, 14%, and 29% for breast cancer mortality were observed, respectively. CONCLUSIONS: Obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained. Being overweight is also related to a higher risk of mortality. Randomised clinical trials are needed to test interventions for weight loss and maintenance on survival in women with breast cancer.
Checked 2026-10-11 · 1 reference not checked yet
Overview
CoChat Summary
## TL;DR
This systematic review and meta-analysis of 82 follow-up studies found that higher BMI was associated with worse overall and breast cancer survival in women with breast cancer, whether BMI was measured before diagnosis, <12 months after, or ≥12 months after diagnosis. It also found some increased mortality risk in overweight and underweight women and evidence of a J-shaped BMI–total mortality relationship.
## Key findings
- Across 79 publications from 82 follow-up studies, the meta-analyses included 41,477 deaths (23,182 from breast cancer) among 213,075 breast cancer survivors.
- For total mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.41 (95% CI 1.29–1.53; 21 studies)
- <12 months after diagnosis: RR 1.23 (95% CI 1.12–1.33; 24 studies)
- ≥12 months after diagnosis: RR 1.21 (95% CI 1.06–1.38; 5 studies)
- For breast cancer mortality, compared with normal-weight women, obese women had higher risk with BMI measured:
- before diagnosis: RR 1.35 (95% CI 1.24–1.47; 22 studies)
- <12 months after diagnosis: RR 1.25 (95% CI 1.10–1.42; 12 studies)
- ≥12 months after diagnosis: RR 1.68 (95% CI 0.90–3.15; 2 studies; not statistically significant)
- Linear dose–response analyses showed increased risk per 5 kg/m² higher BMI:
- Total mortality: RR 1.17 before diagnosis, 1.11 <12 months after, 1.08 ≥12 months after
- Breast cancer mortality: RR 1.18 before diagnosis, 1.14 <12 months after
- The paper reports a J-shaped association for total mortality and notes that risks were also elevated in overweight and, in some analyses, underweight women.
## Methods
- Design: Systematic literature review and meta-analysis of follow-up studies of women with breast cancer.
- Data/sample: English-language articles from OVID MEDLINE and EMBASE through 30 June 2013, plus hand-searching; included studies had to report BMI and total or cause-specific mortality. Final meta-analyses used 79 publications from 82 follow-up studies.
- Main analysis: Random-effects categorical and dose–response meta-analyses, including non-linear dose–response models; heterogeneity assessed with Cochran Q and I², with subgroup/meta-regression, sensitivity analyses, and publication-bias checks using Egger’s test and funnel plots.
## Limitations
- The paper states that most studies did not adjust for co-morbidities and did not assess intentional weight loss; body weight and treatment information were often incomplete or unavailable.
- It notes that reverse causation may have affected studies assessing BMI in women with cancer and other illnesses, and that survival bias in survivor cohorts may underestimate associations.
- The text also says the review could not analyze race/ethnicity or treatment types because too few studies reported them; this is an evident limitation of the evidence base, not just the review.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
0 Valid · 0 Not valid · 9 Not checked · 67 Own results and interpretations
A result the paper states — it cites no source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“BMI was significantly associated with breast cancer mortality.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
states an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“The current systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre and postmenopausal breast cancer, regardless of when BMI is ascertained.”
- Also stated in: § discussion · boosted
“The present systematic literature review and meta-analysis of follow-up studies clearly supports that, in breast cancer survivors, higher BMI is consistently associated with lower overall and breast cancer survival, regardless of when BMI is ascertained.”
- Also stated in: § discussion · plain
“In conclusion, the present systematic literature review and meta-analysis extends and confirms the associations of obesity with an unfavourable overall and breast cancer survival in pre- and post-menopausal breast cancer, regardless of when BMI is ascertained.”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > Abstract
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Also stated in: § discussion · boosted
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Compared with normal weight women, for BMI before diagnosis, the summary RRs were 1.35 (95% CI 1.24–1.47, 22 studies) for obese women, 1.11 (95% CI 1.06–1.17, 21 studies) for overweight women, and 1.02 (95% CI 0.85–1.21, 8 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and breast cancer mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“For BMI ≥12 months after diagnosis, the summary RRs were 1.21 (95% CI 1.06–1.38, 5 studies) for obese women, 0.98 (95% CI 0.86–1.11, 4 studies) for overweight women, and 1.29 (95% CI 1.02–1.63, 3 studies) for underweight women”
§ Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies > results > BMI and total mortality
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
47 more claims
Create a free account to see all 76 claims and to verify the 9 references still open.
- The quote only partly states this claim. 4
- It may state two separate claims as one. 16
- Probably not a substantial claim. 10
Citations
Cites
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“statistical analysis Categorical and dose-response meta-analyses were conducted using random-effects models to account for between-study heterogeneity[18].”
MethodQuantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763 · cited 1×
“To assess heterogeneity, we computed the Cochran Q test and I 2 statistic[35].”
MethodFood, nutrition, physical activity, and the prevention of cancer: a global perspective
(2008) · Choice Reviews Online · doi:10.5860/choice.45-5024 · Cited by 5,350
Finucane, M. M., Stevens, G. A., Cowan, M. J., Danaei, G., Lin, J. K., Paciorek, C. J., Singh, G. M., Gutierrez, H. R., Lu, Y., Bahalim, A. N., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62037-5 · Cited by 4,050 · cited 1×
“be obese and 958 million were overweight in 2008[3].”
BackgroundPublication and related bias in meta-analysis
Sterne, J. A. C., Gavaghan, D., & Egger, M. (2000) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(00)00242-0 · Cited by 2,282 · cited 1×
“Small study or publication bias was examined by Egger’s test[36] and visual inspection of the funnel plots.”
MethodNutrition and physical activity guidelines for cancer survivors
Rock, C. L., Doyle, C., Demark‐Wahnefried, W., Meyerhardt, J., Courneya, K. S., Schwartz, A. L., Bandera, E. V., Hamilton, K. K., Grant, B., McCullough, M., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21142 · Cited by 1,995
Self-citationGeneralized Least Squares for Trend Estimation of Summarized Dose–response Data
Orsini, N., Bellocco, R., & Greenland, S. (2006) · The Stata Journal: Promoting communications on statistics and Stata · doi:10.1177/1536867x0600600103 · Cited by 1,241 · cited 1×
“generalised least-squares for trend estimation[25].”
The use of fractional polynomials to model continuous risk variables in epidemiology
Royston, P., Ambler, G., & Sauerbrei, W. (1999) · International Journal of Epidemiology · doi:10.1093/ije/28.5.964 · Cited by 1,066 · cited 1×
“The non-linear dose-response relationship between BMI and mortality was examined using the best-fitting second order fractional polynomial regression model[23], defined as the one with the lowest deviance.”
MethodFasting Insulin and Outcome in Early-Stage Breast Cancer: Results of a Prospective Cohort Study
Goodwin, P. J., Ennis, M., Pritchard, K. I., Trudeau, M. E., Koo, J., Madarnas, Y., Hartwick, W., Hoffman, B., & Hood, N. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.42 · Cited by 981
Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis
Protani, M., Coory, M., & Martin, J. H. (2010) · Breast Cancer Research and Treatment · doi:10.1007/s10549-010-0990-0 · Cited by 962 · cited 3×
“A review published in 2010 reported statistically significant increased risks of 33% of both total and breast cancer mortality for obesity versus non-obesity around diagnosis[7].”
Background
Research works printed but not linked: 2
- Tobias A Assessing the influence of a single study in meta-analysis Stata Tech Bull 1999 47 15 17
- Donegan WL Jayich S Koehler MR The prognostic implications of obesity for the surgical cure of breast cancer Breast 1978 4 14 17
Cited by
Items 101–200 of 1,000
The Impact of Diabetes on Breast Cancer Treatments and Outcomes: A Population-Based Study
Lega, I. C., Austin, P. C., Fischer, H. D., Fung, K., Krzyzanowska, M. K., Amir, E., & Lipscombe, L. L. (2018) · Diabetes Care · doi:10.2337/dc17-2012 · Cited by 115
Tabung, F. K., Steck, S. E., Liese, A. D., Zhang, J., Ma, Y., Caan, B. J., Chlebowski, R. T., Freudenheim, J. L., Hou, L., Mossavar‐Rahmani, Y., et al. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.98 · Cited by 114
“Obesity or weight gain has been associated with the quality of dietary intake (Fung et al, 2015) and with breast cancer prognosis (Chan et al, 2014; Widschwendter et al, 2015).”
BackgroundThe Role of Adipokines in Breast Cancer: Current Evidence and Perspectives
Christodoulatos, G. S., Spyrou, N., Kadillari, J., Psallida, S., & Dalamaga, Μ. (2019) · Current Obesity Reports · doi:10.1007/s13679-019-00364-y · Cited by 114
Breast cancer and social environment: getting by with a little help from our friends
Hinzey, A., Gaudier-Diaz, M. M., Lustberg, M. B., & DeVries, A. C. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0700-x · Cited by 99
Obesity-Related Digestive Diseases and Their Pathophysiology
Nam, S. Y. (2016) · Gut and Liver · doi:10.5009/gnl15557 · Cited by 113
“Recent meta-analysis using eight studies showed that obesity is associated with poorer overall and breast cancer survival in pre- and post-menopausal breast cancer.(164) Several studies about medical weight reduction strategies showed successful weight reduction in cancer patients.”
MethodZhang, A. M. Y., Xia, Y. H., Lin, J. S. H., Chu, K., Wang, W. C. K., Ruiter, T. J. J., Yang, J. C. C., Chen, N., Chhuor, J., Patil, S., et al. (2023) · Cell Metabolism · doi:10.1016/j.cmet.2023.10.003 · Cited by 113
Reducing Breast Cancer Recurrence: The Role of Dietary Polyphenolics
Braakhuis, A. J., Campion, P., & Bishop, K. S. (2016) · Nutrients · doi:10.3390/nu8090547 · Cited by 111
“Because overweight and obesity are powerful modifiable risk factors [26], interventions, including dietary intervention, should be investigated further.”
BackgroundPhysical activity and cancer risk. Actual knowledge and possible biological mechanisms
Jurdana, M. (2021) · Radiology and Oncology · doi:10.2478/raon-2020-0063 · Cited by 111
Obesity, adipokines and cancer: an update
Lee, C., Woo, Y. C., Wang, Y., Yeung, C., Xu, A., & Lam, K. S. L. (2014) · Clinical Endocrinology · doi:10.1111/cen.12667 · Cited by 109
Ligibel, J. A., Barry, W. T., Alfano, C., Hershman, D. L., Irwin, M., Neuhouser, M., Thomson, C. A., Delahanty, L., Frank, E., Spears, P., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0040-8 · Cited by 102
Association of Obesity-Related Metabolic Disruptions With Cancer Risk and Outcome
Lohmann, A. E., Goodwin, P. J., Chlebowski, R. T., Pan, K., Stambolic, V., & Dowling, R. J. O. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.6187 · Cited by 107
Obesity and Breast Cancer: Not Only a Risk Factor of the Disease
Chan, D. S. M., & Norat, T. (2015) · Current Treatment Options in Oncology · doi:10.1007/s11864-015-0341-9 · Cited by 106
Self-citationPhyto-polyphenols as potential inhibitors of breast cancer metastasis
Avtanski, D. B., & Poretsky, L. (2018) · Molecular Medicine · doi:10.1186/s10020-018-0032-7 · Cited by 105
Sun, L., Zhu, Y., Qian, Q., & Tang, L. (2018) · Medicine · doi:10.1097/md.0000000000011220 · Cited by 104
Obesity and the outcome of young breast cancer patients in the UK: the POSH study
Copson, E., Cutress, R., Maishman, T., Eccles, B., Gerty, S., Stanton, L., Altman, D. G., Durcan, L., Wong, C. Y. Y., Simmonds, P. D., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu509 · Cited by 103
“Our data also support other studies which have found inferior DDFI associated with obesity [4, 5] suggesting that the adverse effect of obesity in this young patient group is due to breast cancer recurrence rather than obesity- associated non-breast cancer mortality.”
BackgroundResultVaysse, C., Lømo, J., Garred, Ø., Fjeldheim, F., Lofterød, T., Schlichting, E., McTiernan, A., Frydenberg, H., Husøy, A., Lundgren, S., et al. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0015-9 · Cited by 102
Self-citationAdipocytes in Breast Cancer, the Thick and the Thin
Rybińska, I., Agresti, R., Trapani, A., Tagliabue, E., & Triulzi, T. (2020) · Cells · doi:10.3390/cells9030560 · Cited by 102
Springer, N. L., Iyengar, N. M., Bareja, R., Verma, A., Jochelson, M. S., Giri, D. D., Zhou, X. K., Elemento, O., Dannenberg, A. J., & Fischbach, C. (2019) · The American Journal of Pathology · doi:10.1016/j.ajpath.2019.06.005 · Cited by 91
“Furthermore, obesity contributes to worse clinical outcome in both premenopausal and postmenopausal breast cancer patients.(6,7) Historically, the link between obesity and breast cancer has been attributed to metabolic dysregulation, altered secretion of adipokines, elevated levels of estrogen, and inflammation.”
BackgroundObesity and Cancer Metastasis: Molecular and Translational Perspectives
Annett, S., Moore, G., & Robson, T. (2020) · Cancers · doi:10.3390/cancers12123798 · Cited by 100
“Furthermore, a meta-analysis of 82 studies found a 41% and 35% higher risk, respectively, of all-cause mortality and breast cancer specific mortality in obese women compared to normal weight women [2].”
BackgroundWen, H., Deng, G., Shi, X., Liu, Z., Lin, A., Cheng, Q., Zhang, J., & Luo, P. (2024) · ESMO Open · doi:10.1016/j.esmoop.2024.102241 · Cited by 99
Lifestyle, nutrition and breast cancer: facts and presumptions for consideration
Ferrini, K., Ghelfi, F., Mannucci, R., & Titta, L. (2015) · ecancermedicalscience · doi:10.3332/ecancer.2015.557 · Cited by 98
“Numerous studies have examined the relationship between obesity and prognosis in breast cancer: the majority of them demonstrate an inverse association between obesity and survival after breast cancer [15, 16].”
Body mass index and prognosis in patients with head and neck cancer
Gama, R. R., Song, Y., Zhang, Q., Brown, M. C., Wang, J. R., Habbous, S., Li, T., Huang, S. H., O’Sullivan, B., Waldron, J. N., et al. (2017) · Head & Neck · doi:10.1002/hed.24760 · Cited by 98
Wang, K., Li, F., Chen, L., Lai, Y., Zhang, X., & Li, H. (2017) · Oncotarget · doi:10.18632/oncotarget.20154 · Cited by 94
“Furthermore, non-users with higher BMI are often associated with elevated risk of BC, which was validated by a comprehensive dose-response metaanalysis [85], indicating that smallest BMI-associated ‘risk gap’ in BC between non-exposure and exposure existed in WHI, which is likely to lead no statistically significant m…”
BackgroundGender Differences in Obesity-Related Cancers
Argyrakopoulou, G., Dalamaga, Μ., Spyrou, N., & Kokkinos, A. D. (2021) · Current Obesity Reports · doi:10.1007/s13679-021-00426-0 · Cited by 94
Prevalence and correlates of cancer-related fatigue in breast cancer survivors
Álvarez‐Bustos, A., de Pedro, C. G., Romero-Elias, M., Ramos, J., Osorio, P., Cantos, B., Maximiano, C., Méndez, M., Fiuza‐Luces, C., Méndez-Otero, M., et al. (2021) · Supportive Care in Cancer · doi:10.1007/s00520-021-06218-5 · Cited by 94
Weight Loss Randomized Intervention Trials in Female Cancer Survivors
Chlebowski, R. T., & Reeves, M. M. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.4026 · Cited by 89
“survivors compared with their healthy-weight counterparts (on the basis of weight prediagnosis and within 12 months postdiagnosis).(1) Against this background of decades of accumulating information regarding the association be-”
BackgroundAriza‐García, A., Lozano‐Lozano, M., Galiano‐Castillo, N., Postigo-Martín, P., Arroyo‐Morales, M., & Cantarero‐Villanueva, I. (2019) · Journal of Medical Internet Research · doi:10.2196/14418 · Cited by 92
“Avoiding poor values related to these variable could be addressed in future studies, given their influence in lower physical conditions [53], chemotherapy toxicities [10,54], recurrence, or mortality [55,56] in patients with breast cancer.”
Lofterød, T., Frydenberg, H., Flote, V. G., Eggen, A. E., McTiernan, A., Mortensen, E., Akslen, L. A., Reitan, J. B., Wilsgaard, T., & Thune, I. (2020) · Breast Cancer Research and Treatment · doi:10.1007/s10549-020-05679-2 · Cited by 92
Self-citationActivation of Canonical BMP4-SMAD7 Signaling Suppresses Breast Cancer Metastasis
Eckhardt, B. L., Cao, Y., Redfern, A. D., Chi, L. H., Burrows, A. D., Roslan, S., Sloan, E. K., Parker, B. S., Loi, S., Ueno, N. T., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-0743 · Cited by 91
Lieberman, D. E., Kistner, T. M., Richard, D., Lee, I.-M., & Baggish, A. L. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2107621118 · Cited by 72
Impact of obesity on breast cancer recurrence and minimal residual disease
Ecker, B. L., Lee, J. Y., Sterner, C. J., Solomon, A. C., Pant, D. K., Shen, F., Peraza, J., Vaught, L. A., Mahendra, S., Belka, G. K., et al. (2019) · Breast Cancer Research · doi:10.1186/s13058-018-1087-7 · Cited by 89
Gibson, J. T., Orlandella, R. M., Turbitt, W. J., Behring, M. P., Manne, U., Sorge, R. E., & Norian, L. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.590794 · Cited by 88
“Excess body weight increases the incidence of 13 types of cancer (2), promotes disease progression (3, 4), impairs antitumor immunity (5, 6), promotes resistance to targeted and chemotherapies (7, 8), and worsens survival for cancer patients (9, 10), especially those with breast cancer.”
BackgroundPang, Y., Wei, Y., & Kartsonaki, C. (2022) · Breast Cancer · doi:10.1007/s12282-022-01355-z · Cited by 87
“A meta-analysis involving 213,075 breast cancer patients and 41,477 deaths [4] showed that the RRs of all-cause mortality comparing obese vs normal weight were 1.”
BackgroundResultInfluentialGolubnitschaja, O. (2017) · The EPMA Journal · doi:10.1007/s13167-017-0086-6 · Cited by 85
“To this end, very recent studies demonstrated a particular attraction of this area, since underweight women seem to be at higher risk specifically for BC with poor outcomes [39].”
BackgroundFortner, R. T., Katzke, V. A., Kuhn, T. E., & Kaaks, R. (2016) · Recent results in cancer research/Recent Results in Cancer Research · doi:10.1007/978-3-319-42542-9_3 · Cited by 85
Endothelin-1 axes in the framework of predictive, preventive and personalised (3P) medicine
Crigna, A. T., Link, B., Samec, M., Giordano, F. A., Kubatka, P., & Golubnitschaja, O. (2021) · The EPMA Journal · doi:10.1007/s13167-021-00248-z · Cited by 82
Obesity and endocrine-related cancer: The important role of IGF-1
Zhong, W., Wang, X., Wang, Y., Sun, G., Zhang, J., & Li, Z. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1093257 · Cited by 81
“Obesity is associated with the occurrence and progression of breast cancer, especially postmenopausal ER+/PR+ breast cancer (30, 31).”
BackgroundNelson, S. H., Marinac, C. R., Patterson, R. E., Nechuta, S., Flatt, S. W., Caan, B. J., Kwan, M. L., Poole, E. M., Chen, W. Y., Shu, X., et al. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3694-2 · Cited by 81
“To date, relatively few studies have investigated post-diagnosis (C12 months) BMI and mortality in breast cancer survivors [19].”
BackgroundMetabolic Syndrome and Breast Cancer: Is There a Link?
Hauner, D., & Hauner, H. (2014) · Breast Care · doi:10.1159/000365951 · Cited by 80
Zaoui, M., Morel, M., Ferrand, N., Fellahi, S., Bastard, J., Lamazière, A., Larsen, A. K., Béréziat, V., Atlan, M., & Sabbah, M. (2019) · Cancers · doi:10.3390/cancers11122012 · Cited by 79
“During the past decade, abundant evidence has associated obesity with an increased incidence of breast cancer [4,5].”
BackgroundBail, J. R., Frugé, A. D., Cases, M. G., De Los Santos, J. F., Locher, J. L., Smith, K. P., Cantor, A. B., Cohen, H. J., & Demark‐Wahnefried, W. (2018) · Cancer · doi:10.1002/cncr.31559 · Cited by 78
Camera, G. L., Gelsomino, L., Malivindi, R., Barone, I., Panza, S., Rose, D. D., Giordano, F., D’Esposito, V., Formisano, P., Bonofiglio, D., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.021 · Cited by 78
Mullooly, M., Yang, H. P., Falk, R. T., Nyante, S. J., Cora, R., Pfeiffer, R. M., Radisky, D. C., Visscher, D. W., Hartmann, L. C., Carter, J. M., et al. (2017) · Breast Cancer Research · doi:10.1186/s13058-016-0791-4 · Cited by 75
“Obesity is linked to a 25% increase in the risk of developing breast cancer, and a recent meta-analysis of 82 studies found a 34% higher overall mortality risk among obese as compared with lean postmenopausal breast cancer patients [1 – 4].”
The Effects of Metformin and Weight Loss on Biomarkers Associated With Breast Cancer Outcomes
Patterson, R. E., Marinac, C. R., Sears, D. D., Kerr, J., Hartman, S. J., Cadmus‐Bertram, L., Villaseñor, A., Flatt, S. W., Godbole, S. V., Li, H., et al. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy040 · Cited by 78
Chan, D. S. M., Vieira, R. D. C. P. A., Abar, L., Aune, D., Balducci, K., Cariolou, M., Greenwood, D. C., Markozannes, G., Nanu, N., Becerra‐Tomás, N., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34322 · Cited by 77
Self-citationOrmel, H. L., van der Schoot, G. G. F., Westerink, N.-D. L., Sluiter, W. J., Gietema, J. A., & Walenkamp, A. (2018) · Supportive Care in Cancer · doi:10.1007/s00520-018-4263-5 · Cited by 77
Obesity as risk factor for subtypes of breast cancer: results from a prospective cohort study
Nattenmüller, C. J., Kriegsmann, M., Sookthai, D., Fortner, R. T., Steffen, A., Walter, B., Johnson, T., Kneisel, J., Katzke, V. A., Bergmann, M. M., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4548-6 · Cited by 77
“hormone receptor status of the tumor [35, 36].”
Microbiome, bile acids, and obesity: How microbially modified metabolites shape anti‐tumor immunity
Sipe, L. M., Chaib, M., Pingili, A. K., Pierre, J. F., & Makowski, L. (2020) · Immunological Reviews · doi:10.1111/imr.12856 · Cited by 78
Natural and Synthetic Estrogens in Chronic Inflammation and Breast Cancer
Maharjan, C. K., Mo, J., Wang, L. A., Kim, M., Wang, S., Borcherding, N. C., Vikas, P., & Zhang, W. (2021) · Cancers · doi:10.3390/cancers14010206 · Cited by 76
Modeling Diet-Induced Obesity with Obesity-Prone Rats: Implications for Studies in Females
Giles, E. D., Jackman, M. R., & MacLean, P. S. (2016) · Frontiers in Nutrition · doi:10.3389/fnut.2016.00050 · Cited by 77
Cardiometabolic risk factors and survival after cancer in the Women's Health Initiative
Simon, M. S., Hastert, T. A., Barac, A., Banack, H. R., Caan, B. J., Chlebowski, R. T., Foraker, R. E., Hovsepyan, G., Liu, S., Luo, J., et al. (2020) · Cancer · doi:10.1002/cncr.33295 · Cited by 75
George, S. M., Bernstein, L., Smith, A. W., Neuhouser, M. L., Baumgartner, K. B., Baumgartner, R., & Ballard-Barbash, R. R. (2014) · Breast Cancer Research and Treatment · doi:10.1007/s10549-014-3048-x · Cited by 74
Harborg, S., Zachariae, R. H., Olsen, J., Johannsen, M., Cronin-Fenton, D. P., Bøggild, H., & Borgquist, S. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00325-6 · Cited by 71
Tang, W., Putluri, V., Ambati, C. R., Dorsey, T. H., Putluri, N., & Ambs, S. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-0094 · Cited by 71
Identifying key barriers to effective breast cancer control in rural settings
Sprague, B. L., Ahern, T. P., Herschorn, S. D., Sowden, M., Weaver, D. L., & Wood, M. E. (2021) · Preventive Medicine · doi:10.1016/j.ypmed.2021.106741 · Cited by 70
Long-Term Quality of Life (BREAST-Q) in Patients with Mastectomy and Breast Reconstruction
García-Solbas, S., Lorenzo-Liñán, M. Á., & Castro-Luna, G. M. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18189707 · Cited by 70
“In contrast, other studies have shown that obesity is associated with worse outcomes and poorer survival in women with breast cancer [28].”
ResultEngin, A. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-63657-8_1 · Cited by 70
Kampshoff, C. S., Stacey, F. G., Short, C. E., van Mechelen, W., Chinapaw, M. J. M., Brug, J., Plotnikoff, R. C., James, E. L., & Buffart, L. M. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3148-8 · Cited by 70
Bandera, E. V., Qin, B., Lin, Y., Zeinomar, N., Xu, B., Chanumolu, D., Llanos, A. A. M., Omene, C. O., Pawlish, K. S., Ambrosone, C. B., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.1499 · Cited by 71
Self-citationObesity and endocrine therapy resistance in breast cancer: Mechanistic insights and perspectives
Barone, I., Caruso, A., Gelsomino, L., Giordano, C., Bonofiglio, D., Catalano, S., & Andò, S. (2021) · Obesity Reviews · doi:10.1111/obr.13358 · Cited by 69
Majumder, K., Gupta, A., Arora, N., Singh, P. P., & Singh, S. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.09.036 · Cited by 64
Leptin signaling and cancer chemoresistance: Perspectives
Candelaria, P. V., Rampoldi, A., Harbuzariu, A., & Gonzalez-Perez, R. R. (2017) · World Journal of Clinical Oncology · doi:10.5306/wjco.v8.i2.106 · Cited by 69
Cancer survivorship, excess body fatness and weight-loss intervention—where are we in 2020?
Anderson, A. S., Martin, R. M., Renehan, A. G., Cade, J. E., Copson, E., Cross, A. J., Grimmett, C., Keaver, L., King, A., Ríboli, E., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-01155-2 · Cited by 69
“A meta-analysis of 82 studies reported a 35% increase in breast-cancer-related mortality and a 41% increase in all-cause mortality in women with breast cancer who were obese, independent of menopausal status.(17) Similarly, meta-analyses suggest that obesity is associated with poorer survival outcomes in bladder,(18)…”
Obesity and Cancer Treatment Outcomes: Interpreting the Complex Evidence
Slawinski, C. G. V., Barriuso, J., Guo, H., & Renehan, A. G. (2020) · Clinical Oncology · doi:10.1016/j.clon.2020.05.004 · Cited by 63
Ke, J., Banh, T., Hsiao, Y., Cole, R. M., Straka, S. R., Yee, L. D., & Belury, M. A. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600934 · Cited by 67
“Accumulating evidence from preclinical and clinical studies reveals an association between obesity and increased incidence, morbidity, and mortality of postmenopausal breast cancer [1, 29, 30].”
BackgroundMaliniak, M. L., Patel, A. V., McCullough, M. L., Campbell, P. T., Leach, C. R., Gapstur, S. M., & Gaudet, M. M. (2017) · Breast Cancer Research and Treatment · doi:10.1007/s10549-017-4470-7 · Cited by 68
Toohey, K. L., Pumpa, K. L., McKune, A. J., Cooke, J., & Semple, S. (2017) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-017-2552-x · Cited by 67
“Excess fat mass is associated with poorer overall survival of some cancers and being overweight has been linked to a higher risk of mortality in breast, ovarian, lung and colorectal cancer (Bae et al. 2014; Chan et al. 2014; Taghizadeh et al. 2015).”
BackgroundCifu, G., & Arem, H. E. (2018) · Annals of Epidemiology · doi:10.1016/j.annepidem.2018.09.002 · Cited by 67
Adiposity and cancer survival: a systematic review and meta-analysis
Cheng, E., Kirley, J., Feliciano, E. M. C., & Caan, B. J. (2022) · Cancer Causes & Control · doi:10.1007/s10552-022-01613-7 · Cited by 66
The Emerging Role of Adiponectin in Female Malignancies
Gelsomino, L., Naimo, G. D., Catalano, S., Mauro, L., & Andò, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092127 · Cited by 68
“Obese female breast cancer patients are more likely to have a worse prognosis [170] and recent meta-analyses also estimated an approximately 30% increased risk of disease recurrence or death in obese versus normal weight women [171,172].”
BackgroundPretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression
Ferroni, P., Riondino, S., Laudisi, A., Portarena, I., Formica, V., Alessandroni, J., D’Alessandro, R., Orlandi, A., Costarelli, L., Cavaliere, F., et al. (2016) · The Oncologist · doi:10.1634/theoncologist.2015-0462 · Cited by 65
Bakar, D., & Mehrzad, R. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-90965-5.00006-4 · Cited by 65
Body mass index and breast cancer survival: a Mendelian randomization analysis
Guo, Q., Burgess, S., Turman, C., Bolla, M. K., Wang, Q., Lush, M., Abraham, J., Aittomäki, K., Andrulis, I. L., Apicella, C., et al. (2017) · International Journal of Epidemiology · doi:10.1093/ije/dyx131 · Cited by 64
The Future of Breast Cancer Research in the Survivorship Field
Soldato, D., Arecco, L., Agostinetto, E., Franzoi, M. A., Mariamidze, E., Begijanashvili, S., Brunetti, N., Spinaci, S., Solinas, C., Vaz-Luís, I., et al. (2023) · Oncology and Therapy · doi:10.1007/s40487-023-00225-8 · Cited by 65
“05), although these last data were not significant and not confirmed in other studies [140].”
ResultTrestini, I., Carbognin, L., Monteverdi, S., Zanelli, S., Toma, A. D., Bonaiuto, C., Nortilli, R., Fiorio, E., Pilotto, S., Maïo, M. D., et al. (2018) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2018.06.011 · Cited by 64
Becerra‐Tomás, N., Balducci, K., Abar, L., Aune, D., Cariolou, M., Greenwood, D. C., Markozannes, G., Nanu, N., Vieira, R. D. C. P. A., Giovannucci, E. L., et al. (2022) · International Journal of Cancer · doi:10.1002/ijc.34321 · Cited by 64
Self-citationEfficacy of a Weight Loss Intervention for African American Breast Cancer Survivors
Stolley, M., Sheean, P., Gerber, B., Arroyo, C., Schiffer, L., Banerjee, A., Visotcky, A., Fantuzzi, G., Strahan, D., Matthews, L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.71.9856 · Cited by 57
“Evidence from a 2014 meta-analysis of 82 studies found that prediagnosis and postdiagnosis obesity was associated with higher breast cancer– specific and overall mortality; overweight was associated with higher overall mortality.(8) Over 82% of AA women are classified as overweight/ obese, and 56.”
MethodLifestyle Patterns and Survival Following Breast Cancer in the Carolina Breast Cancer Study
Parada, H., Sun, X., Tse, C., Olshan, A. F., & Troester, M. A. (2018) · Epidemiology · doi:10.1097/ede.0000000000000933 · Cited by 63
Demark‐Wahnefried, W., Rogers, L. Q., Gibson, J. T., Harada, S., Frugé, A. D., Oster, R. A., Grizzle, W. E., Norian, L. A., Yang, E. S.-H., Manna, D. D., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32637 · Cited by 63
Breast cancer microenvironment and obesity: challenges for therapy
Hillers‐Ziemer, L. E., Kuziel, G. M., Williams, A. E., Moore, B. N., & Arendt, L. M. (2022) · Cancer and Metastasis Reviews · doi:10.1007/s10555-022-10031-9 · Cited by 63
Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741 (Alliance)
Ligibel, J. A., Cirrincione, C., Liu, M., Citron, M. L., Ingle, J. N., Gradishar, W. J., Martino, S., Sikov, W. M., Michaelson, R. A., Mardis, E. R., et al. (2015) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv179 · Cited by 62
“a r t ic le a r t ic le on this topic reported a 34% increase in breast cancer–related mortality and a 41% increase in overall mortality in women who were obese at the time of breast cancer diagnosis as compared with women who were of normal weight (4).”
BackgroundPropranolol and survival from breast cancer: a pooled analysis of European breast cancer cohorts
Cardwell, C. R., Pottegård, A., Vaes, E., Garmo, H., Murray, L., Brown, C. S. B., Vissers, P. A. J., O’Rorke, M. A., Visvanathan, K., Cronin-Fenton, D. P., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0782-5 · Cited by 62
“The lack of adjustment for BMI could have attenuated propranolol associations because breast cancer patients with higher BMI have worse survival [41].”
BackgroundKawai, M., Tomotaki, A., Miyata, H., Iwamoto, T., Niikura, N., Anan, K., Hayashi, N., Aogi, K., Ishida, T., Masuoka, H., et al. (2016) · Cancer Medicine · doi:10.1002/cam4.678 · Cited by 61
Sex differences in anthracycline-induced cardiotoxicity: the benefits of estrogens
Dessalvi, C. C., Pepe, A., Penna, C. R. R., Gimelli, A., Madonna, R., Mele, D., Monte, I. P., Novo, G., Nugara, C., Zito, C., et al. (2019) · Heart Failure Reviews · doi:10.1007/s10741-019-09820-2 · Cited by 61
“In addition, previous studies demonstrated that obesity was an important prognostic factor that affected both overall survival and disease-free survival in patients with breast cancer [13].”
Pregnancy-associated breast cancer: the risky status quo and new concepts of predictive medicine
Polívka, J., Altun, I., & Golubnitschaja, O. (2018) · The EPMA Journal · doi:10.1007/s13167-018-0129-7 · Cited by 60
“Abnormally low BMI is less investigated in the context of BM.”
BackgroundInfluentialThe LISA randomized trial of a weight loss intervention in postmenopausal breast cancer
Goodwin, P. J., SEGAL, R. J., Vallis, M., Ligibel, J. A., Pond, G. R., Robidoux, A., Findlay, B., Gralow, J. R., Mukherjee, S. D., Levine, M. N., et al. (2020) · npj Breast Cancer · doi:10.1038/s41523-020-0149-z · Cited by 60
Insulin/IGF Axis in Breast Cancer: Clinical Evidence and Translational Insights
Biello, F., Platini, F., D’Avanzo, F., Cattrini, C., Mennitto, A., Genestroni, S., Martini, V., Marzullo, P., Aimaretti, G., & Gennari, A. (2021) · Biomolecules · doi:10.3390/biom11010125 · Cited by 60
“Compared with normal weight women, significant or borderline significant increased risks of BC mortality were only observed for morbidly obese (≥40 kg/m2) women and not for women in other obesity categories [38].”
BackgroundKämmerer, U., Klement, R. J., Joos, F., Sütterlin, M., & Reuss-Borst, M. A. (2021) · Nutrients · doi:10.3390/nu13031029 · Cited by 60
How to Manage the Obese Patient With Cancer
Renehan, A. G., Harvie, M., Cutress, R. I., Leitzmann, M., Pischon, T., Howell, S., & Howell, A. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.1899 · Cited by 57
Cell shape alteration during adipogenesis is associated with coordinated matrix cues
Moldovan, L. M., Lustig, M., Naftaly, A., Mardamshina, M., Geiger, T., Gefen, A., & Benayahu, D. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27157 · Cited by 59
Reeves, M., Winkler, E., Mccarthy, N., Lawler, S., Terranova, C., Hayes, S., Janda, M., Demark-Wahnefried, W., & Eakin, E. (2017) · Asia-Pacific Journal of Clinical Oncology · doi:10.1111/ajco.12629 · Cited by 58
Ligibel, J. A., Alfano, C. M., Hershman, D. L., Ballard, R., Bruinooge, S. S., Courneya, K. S., Daniels, E. C., Demark‐Wahnefried, W., Frank, E. S., Goodwin, P. J., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.1440 · Cited by 58
Zuo, T., Zeng, H., Li, H., Liu, S., Yang, L., Xia, C., Zheng, R., Ma, F., Liu, L., Wang, N., et al. (2017) · 癌症:英文版 · doi:10.1186/s40880-017-0250-3 · Cited by 58
“BMI and histological grade are significant indicators associated with breast cancer patient survival apart from stage at diagnosis and molecular subtype, which had been reported in previous studies [41, 42].”
ResultLu, L., Mulligan, J. A., Ouyang, Y., Shimpi, A. A., Williams, R. M., Beeghly, G. F., Hopkins, B. D., Spector, J. A., Adie, S. G., & Fischbach, C. (2020) · Advanced Functional Materials · doi:10.1002/adfm.201910650 · Cited by 58
Impact of body mass index on overall survival in patients with metastatic breast cancer
Saleh, K., Carton, M., Dieras, V. C., Heudel, P., Brain, E. G. C., D’Hondt, V., Mailliez, A., Patsouris, A., Mouret‐Reynier, M., Gonçalvès, A., et al. (2020) · The Breast · doi:10.1016/j.breast.2020.11.014 · Cited by 57
“While, in patients with early breast cancer, underweight is not associated with overall and BC specific survival [28], underweight at metastatic diagnosis seems to have a different significance and impact.”
BackgroundModi, N. D., Tan, E., Rowland, A., Koczwara, B., Abuhelwa, A. Y., Kichenadasse, G., McKinnon, R. A., Wiese, M. D., Sorich, M. J., & Hopkins, A. M. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00241-9 · Cited by 57
Kiss, N., Baguley, B. J., Ball, K., Daly, R. M., Fraser, S. F., Granger, C. L., & Ugalde, A. (2019) · JMIR mhealth and uhealth · doi:10.2196/12281 · Cited by 56
“Conversely, obesity after treatment completion is associated with reduced cancer survival; nonetheless, less than 20% of cancer survivors meet the dietary recommendations and less than 50% meet the physical activity recommendations, demonstrating a clear role for interventions to support healthy eating behaviors and i…”
BackgroundBody weight management in overweight and obese breast cancer survivors
Li, X., Bulsara, M. K., Tan, S. Y., & Vardy, J. L. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012110 · Cited by 56
Kalezic, A., Udicki, M., Srdić, B., Aleksic, M., Korać, A., Janković, A., & Korać, B. (2021) · Cancers · doi:10.3390/cancers13112731 · Cited by 56
Wang, J., Zhang, W., Liu, C., Wang, L., Wu, J., Sun, C., & Wu, Q. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.92125 · Cited by 56
Metadata
- Authors
- Chan, D. S. M., Vieira, A. R., Aune, D., Bandera, E. V., Greenwood, D. C., McTiernan, A., Navarro Rosenblatt, D., Thune, I., Vieira, R., & Norat, T.
- Affiliations
- Imperial College London (GB)
- Norwegian University of Science and Technology (NO)
- Rutgers, The State University of New Jersey (US)
- University of Leeds (GB)
- Fred Hutch Cancer Center (US)
- Oslo University Hospital (NO)
- Newcastle University (GB)
- Corresponding author
- Chan, D.S.M.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2014-10
- Volume
- 25
- Issue
- 10
- Pages
- 1901-1914
- ISSN
- 0923-7534 (ISSN-L)
- PMC
- PMC4176449
- OpenAlex
- W2149466392
- Cited by
- 1,165
- References
- 123
- Citations by year
- 2026: 57 · 2025: 69 · 2024: 97 · 2023: 117 · 2022: 132 · 2021: 117 · 2020: 121 · 2019: 103 · 2018: 97 · 2017: 98 · 2016: 85 · 2015: 58 · 2014: 12
- FWCI
- 9.58
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by-nc-nd/4.0/ (vor, 1878 d)
- Locations
- Annals of Oncology (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Rutgers University Community Repository (Rutgers University) (submittedVersion)
- Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc)
- NORA - Norwegian Open Research Archives (submittedVersion, other-oa)
- NORA - Norwegian Open Research Archives (submittedVersion, cc-by-nc-nd)
- HighWire Press Open Archive (submittedVersion)
- Funders
- World Cancer Research Fund International (2007/SP01)
- World Cancer Research Fund International/American Institute for Cancer Research
- Topics
- Health Sciences › Medicine › Oncology › Cancer Risks and Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Obesity, Physical Activity, Diet
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- body mass index, breast cancer, obesity, overweight, underweight, survival, mortality, cause-specific mortality, menopausal status, weight loss interventions, cancer survivorship
- MeSH terms
- Breast Neoplasms, Female, Follow-Up Studies, Humans, Obesity, Prognosis, Risk Factors, Body Mass Index, Randomized Controlled Trials as Topic, MEDLINE, Survivors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-11, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-11 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.